allfeeds.ai

 

The Allergist  

The Allergist

Author: CSACI

Welcome to your allergy lifeline..."The Allergist."  A show that separates myth from medicine. Every episode of The Allergist is designed for YOU the medical professional aiming to stay on the cutting edge of allergy care. We'll clarify, correct, and, most importantly, contextualize the latest evidence.
Be a guest on this podcast

Language: en-us

Genres: Health & Fitness, Medicine

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Trailer:


Get all podcast data

Listen Now...

Rewriting the Immune Code
Tuesday, 17 March, 2026

"So the future is one IV infusion, likely no chemotherapy, and that'll cure our IEIs." — Dr. Nicola WrightFor children born with inborn errors of immunity, bone marrow transplant has long been the closest thing medicine had to a cure. It works — but it comes with chemotherapy, graft-versus-host disease, and a donor search that doesn't always end well. Gene therapy is changing that calculus. Dr. Mariam Hanna speaks with Dr. Nicola Wright, a pediatric hematologist and clinical immunologist at the Alberta Children's Hospital and holder of the Barb Ibbotson Chair of Pediatric Hematology, whose research focuses on developing gene editing platforms for blood and immune disorders.On this episode, they discuss:Why bone marrow transplant is, in Dr. Wright's words, "almost a poor man's gene therapy" and what gene therapy offers insteadThe spectrum of technologies: lentiviral insertion, CRISPR, base editing, and prime editing. What each does, and where each falls shortImmune reconstitution outcomes across diseases, including over 90% good immune reconstitution in ADA-deficient SCID treated with lentiviral therapyHow to counsel a family when gene therapy might be an option and why most patients still can't access itThe "valley of death": why therapies that work in trials are failing to reach patients, and what it will take to cross itCAR T-cell therapy in IEI, including a Canadian trial underway for refractory autoimmune diseaseWhat long-term follow-up looks like and why 15-year post-trial monitoring is now an FDA requirementThe science is outpacing the infrastructure. Dr. Wright's vision of shipping cells instead of patients, in vivo delivery via lipid nanoparticle, no chemotherapy required isn't speculative. The runway is being built. The plane is already flying.Have an idea for the show or a comment, send us a text!Visit the Canadian Society of Allergy and Clinical ImmunologyFind an allergist using our helpful toolFind Dr. Hanna on X, previously Twitter, @PedsAllergyDoc or CSACI @CSACI_caThe Allergist is produced for CSACI by PodCraft Productions

 

We also recommend:


ACP2012-podcast
Geoff Cross

Redeeming Disorder
Reiman Bledsoe

Radio iRemedy
Tony Paquin

Periop Talk
Association of periOperative Registered Nurses (AORN)

Physician Interrupted
Kernan Manion MD

Fatal Neglect: Forgotten issues in child health - UCL Global Health Symposium - Audio
UCL

Alcohol and Pregnancy: The More You Know
Boston Medical Center: B Smart Program

RP's Ortho Notes
Rajesh Purushothaman

Estética pero no plástica
Linda Lorena Rincon Rubio

Double Dose: with Dr. Trish & PA Jeff
2911 Healthcare LLC

Tablettentalk | Der Apotheken-Podcast
Marie und Tabea


DEGA